MedTrace Logo

IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

NCT05945576 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-02-12

No results posted yet for this study

Summary

The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adults and children) affected with an ID regardless of the severity of the disease, with a molecular characterization, with a signed informed consent for all subjects, followed in one partner's center.

The main questions it aims to answer are:

* Can we identify common metabolic profiles for all imprinted diseases?
* Which imprinting disorders have an impact on the metabolic profiles of IDs?
* Which are the metabolic risks associated to IDs?
* Can we use the metabolic profiles for the clinical classification and prognosis of IDs?
* Are there common therapeutic approaches for all IDs?

Conditions

  • Silver Russell Syndrome
  • Beckwith-Wiedemann Syndrome
  • Transient Neonatal Diabetes Mellitus
  • Angelman Syndrome
  • Prader-Willi Syndrome
  • Temple Syndrome
  • Kagami-Ogata Syndrome
  • Pseudohypoparathyroidism
  • Familial Precocious Puberty

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Agnès LINGLART · Inserm U1169

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-10
Primary Completion
2028-03-31
Completion
2028-03-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05945576 on ClinicalTrials.gov